14The Systemic Work-up: History, Examination and the Rational Blood Panel

FHistory first: the work-up begins with questions

The single highest-yield investigation in systemic tinnitus is a structured history. Constitutional symptoms (weight change, fevers, night sweats, fatigue), a full drug list including over-the-counter analgesics and supplements, dietary pattern, and known comorbidities frequently localise the problem before any sample is drawn [2013]. Tinnitus is a symptom, not a disease, so the history is aimed at the body behind it.

Targeted prompts pay off: heat or cold intolerance and palpitations point to thyroid disease; polyuria, thirst and a vascular risk profile to diabetes; pallor, breathlessness and heavy menses to anaemia; jaw claudication and visual symptoms in an older patient to giant-cell arteritis. The history converts an open-ended complaint into a short list of testable hypotheses [2013].

TExamination: looking for the systemic clue

Examination extends the history. Blood pressure and pulse (rate and rhythm) screen for hypertension and arrhythmia; conjunctival and palmar pallor suggest anaemia; a goitre, tremor or lid lag flags thyroid disease; BMI and acanthosis nigricans hint at metabolic syndrome. A focused otological examination remains essential to exclude local causes that masquerade as systemic ones.

For pulsatile tinnitus, auscultation over the neck, mastoid and periauricular region for a bruit, and a check for whether light neck-vessel compression alters the sound, can redirect the work-up toward a vascular cause entirely. The aim is to decide which bloods are actually justified, not to order a panel and hope [2014].

CThe rational blood panel: test by test, with the reason

A defensible first-line panel, ordered selectively, covers the common treatable systemic drivers. A full blood count screens for anaemia and, occasionally, platelet abnormalities; thyroid function tests for hypo- or hyperthyroidism; fasting glucose or HbA1c for diabetes and dysglycaemia; and a lipid profile because dyslipidaemia is associated with tinnitus through cochlear microvascular effects [2025]. Each of these maps to a condition with a specific treatment.

Second-line, suspicion-driven tests deepen the search: vitamin B12 and folate for deficiency states (especially in older, vegetarian, or metformin- or PPI-treated patients); ferritin and iron studies, particularly in menstruating women, where iron-deficiency anaemia is associated with new-onset tinnitus [2025]; ESR and CRP when an inflammatory or giant-cell-arteritis picture is suspected; an autoimmune screen (ANA, RF, ANCA) when rapidly progressive bilateral hearing loss suggests autoimmune inner-ear disease; and renal and liver function where uraemia, electrolyte disturbance or hepatic disease is plausible [2025].

COrdering by suspicion, not by reflex

Guidelines do not endorse a blanket battery of blood tests for every patient with tinnitus; investigations should follow red flags and the history-and-examination findings [2014]. Indiscriminate panels generate incidental abnormalities, anxiety and cost without improving outcomes. The skill is matching the test to the clinical question.

The corollary is that a positive, treatable result is genuinely worth finding. Correcting a deficiency, controlling glycaemia, treating thyroid dysfunction, or starting steroids for arteritis can resolve or substantially reduce tinnitus when the systemic driver is the real cause — which is precisely why the targeted, hypothesis-led panel earns its place [2013].